rs2296435

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_000195.5(HPS1):​c.1599-15A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.247 in 1,612,042 control chromosomes in the GnomAD database, including 52,105 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). There are indicators that this mutation may affect the branch point..

Frequency

Genomes: 𝑓 0.22 ( 4245 hom., cov: 33)
Exomes 𝑓: 0.25 ( 47860 hom. )

Consequence

HPS1
NM_000195.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.670

Publications

19 publications found
Variant links:
Genes affected
HPS1 (HGNC:5163): (HPS1 biogenesis of lysosomal organelles complex 3 subunit 1) This gene encodes a protein that may play a role in organelle biogenesis associated with melanosomes, platelet dense granules, and lysosomes. The encoded protein is a component of three different protein complexes termed biogenesis of lysosome-related organelles complex (BLOC)-3, BLOC4, and BLOC5. Mutations in this gene are associated with Hermansky-Pudlak syndrome type 1. Alternative splicing results in multiple transcript variants. A pseudogene related to this gene is located on chromosome 22. [provided by RefSeq, Aug 2015]
HPS1 Gene-Disease associations (from GenCC):
  • Hermansky-Pudlak syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae)
  • Hermansky-Pudlak syndrome with pulmonary fibrosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
This position, referring to a specific DNA site, is a probable branch point but is likely benign (scored 3 / 10, using the threshold of <=3). The score ranges from 0 to 10, with values ≤3 considered benign and >5 classified as pathogenic. Computational evidence support a benign effect (BayesDel_noAF=-0.38).
BP6
Variant 10-98422528-T-C is Benign according to our data. Variant chr10-98422528-T-C is described in ClinVar as Benign. ClinVar VariationId is 167184.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.379 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000195.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HPS1
NM_000195.5
MANE Select
c.1599-15A>G
intron
N/ANP_000186.2
HPS1
NM_001322476.2
c.1599-15A>G
intron
N/ANP_001309405.1
HPS1
NM_001322477.2
c.1599-15A>G
intron
N/ANP_001309406.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HPS1
ENST00000361490.9
TSL:1 MANE Select
c.1599-15A>G
intron
N/AENSP00000355310.4
HPS1
ENST00000467246.5
TSL:1
n.*958-15A>G
intron
N/AENSP00000514163.1
ENSG00000289758
ENST00000699159.1
n.*958-15A>G
intron
N/AENSP00000514167.1

Frequencies

GnomAD3 genomes
AF:
0.224
AC:
33978
AN:
152018
Hom.:
4242
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.135
Gnomad AMI
AF:
0.263
Gnomad AMR
AF:
0.282
Gnomad ASJ
AF:
0.312
Gnomad EAS
AF:
0.357
Gnomad SAS
AF:
0.394
Gnomad FIN
AF:
0.223
Gnomad MID
AF:
0.241
Gnomad NFE
AF:
0.237
Gnomad OTH
AF:
0.219
GnomAD2 exomes
AF:
0.271
AC:
67930
AN:
250900
AF XY:
0.277
show subpopulations
Gnomad AFR exome
AF:
0.133
Gnomad AMR exome
AF:
0.305
Gnomad ASJ exome
AF:
0.314
Gnomad EAS exome
AF:
0.339
Gnomad FIN exome
AF:
0.228
Gnomad NFE exome
AF:
0.239
Gnomad OTH exome
AF:
0.257
GnomAD4 exome
AF:
0.249
AC:
363790
AN:
1459906
Hom.:
47860
Cov.:
36
AF XY:
0.254
AC XY:
184776
AN XY:
726354
show subpopulations
African (AFR)
AF:
0.135
AC:
4513
AN:
33462
American (AMR)
AF:
0.303
AC:
13547
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.312
AC:
8155
AN:
26120
East Asian (EAS)
AF:
0.362
AC:
14344
AN:
39678
South Asian (SAS)
AF:
0.405
AC:
34936
AN:
86206
European-Finnish (FIN)
AF:
0.231
AC:
12256
AN:
52972
Middle Eastern (MID)
AF:
0.305
AC:
1759
AN:
5766
European-Non Finnish (NFE)
AF:
0.233
AC:
258923
AN:
1110664
Other (OTH)
AF:
0.255
AC:
15357
AN:
60322
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
13704
27408
41111
54815
68519
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8966
17932
26898
35864
44830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.223
AC:
33993
AN:
152136
Hom.:
4245
Cov.:
33
AF XY:
0.228
AC XY:
16935
AN XY:
74370
show subpopulations
African (AFR)
AF:
0.135
AC:
5620
AN:
41528
American (AMR)
AF:
0.283
AC:
4327
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.312
AC:
1080
AN:
3464
East Asian (EAS)
AF:
0.356
AC:
1832
AN:
5140
South Asian (SAS)
AF:
0.394
AC:
1895
AN:
4814
European-Finnish (FIN)
AF:
0.223
AC:
2364
AN:
10588
Middle Eastern (MID)
AF:
0.235
AC:
69
AN:
294
European-Non Finnish (NFE)
AF:
0.237
AC:
16105
AN:
67982
Other (OTH)
AF:
0.218
AC:
461
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1346
2691
4037
5382
6728
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
386
772
1158
1544
1930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.237
Hom.:
1106
Bravo
AF:
0.219
Asia WGS
AF:
0.330
AC:
1146
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Feb 26, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

1599-15A>G in intron 16 of HPS1: This variant is not expected to have clinical s ignificance because it has been identified in 24.0% (2061/8600) of European Amer ican chromosomes from a broad population by the NHLBI Exome Sequencing Project ( http://evs.gs.washington.edu/EVS; dbSNP rs2296435).

not provided Benign:3
Apr 07, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Hermansky-Pudlak syndrome 1 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.38
CADD
Benign
17
DANN
Benign
0.79
PhyloP100
0.67
BranchPoint Hunter
3.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2296435; hg19: chr10-100182285; COSMIC: COSV57267541; COSMIC: COSV57267541; API